206
Views
47
CrossRef citations to date
0
Altmetric
Review

Localized neuropathic pain: an expert consensus on local treatments

, , , &
Pages 2709-2718 | Published online: 13 Sep 2017

References

  • TreedeR-DJensenTSCampbellJNNeuropathic pain: redefinition and a grading system for clinical and research purposesNeurology20087018 1630 163518003941
  • IASP [webpage on the Internet]Taskforce on Taxonomy2011 [cited Nov 15, 2016]. Available from: http://www.iasp-pain.org/TaxonomyAccessed July 5, 2017
  • MorelVJolyDVillatteCMemantine before mastectomy prevents post-surgery pain: a randomized, blinded clinical trial in surgical patientsPLoS One2016114 e015274127050431
  • PickeringGGavazziGGaillatJPaccalinMBlochKBouhassiraDIs herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort studyBMJ Open201662 e009689
  • GavazziGHerpes Zoster and Functional Decline ConsortiumPickeringGSchmaderKFunctional decline and herpes zoster in older people: an interplay of multiple factorsAging Clin Exp Res2015276 757 76526440662
  • BouhassiraDLantéri-MinetMAttalNLaurentBTouboulCPrevalence of chronic pain with neuropathic characteristics in the general populationPain20081363 380 38717888574
  • MarchettiniPLacerenzaMMauriEMarangoniCPainful peripheral neuropathiesCurr Neuropharmacol200643 175 18118615140
  • BrownMRRamirezJDFarquhar-SmithPPain in cancer survivorsBr J Pain201484 139 15326516548
  • MickGCorrea-IllanesGTopical pain management with the 5% lidocaine medicated plaster – a reviewCurr Med Res Opin2012286 937 95122551228
  • DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain20071323 237 25117920770
  • van HeckeOKamermanPRAttalNNeuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendationsPain201515611 2337 235326469320
  • DengYLuoLHuYFangKLiuJClinical practice guidelines for the management of neuropathic pain: a systematic reviewBMC Anesthesiol201616 1226892406
  • FinnerupNBAttalNHaroutounianSPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisLancet Neurol2015142 162 17325575710
  • MickGBaronRFinnerupNBWhat is localized neuropathic pain? A first proposal to characterize and define a widely used termPain Manag201221 71 7724654620
  • CasaleRSymeonidouZBartoloMTopical treatments for localized neuropathic painCurr Pain Headache Rep2017213 1528271334
  • DerrySWiffenPJKalsoEATopical analgesics for acute and chronic pain in adults – an overview of Cochrane reviewsCochrane Database Syst Rev20175 CD00860928497473
  • BergerADukesEMOsterGClinical characteristics and economic costs of patients with painful neuropathic disordersJ Pain200453 143 14915106126
  • YawnBPWollanPCWeingartenTNWatsonJCHootenWMMeltonLJThe prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community populationPain Med2009103 586 59320849570
  • BennettMThe LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signsPain2001921–2 147 15711323136
  • BennettMISmithBHTorranceNPotterJThe S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal researchJ Pain200563 149 15815772908
  • FinePGChronic pain management in older adults: special considerationsJ Pain Symptom Manage2009382 suppl S4 S1419671470
  • BaronRBinderAWasnerGNeuropathic pain: diagnosis, pathophysiological mechanisms, and treatmentLancet Neurol201098 807 81920650402
  • DualéCOuchchaneLSchoefflerPEDONIS Investigating GroupDubrayCNeuropathic aspects of persistent postsurgical pain: a French multicenter survey with a 6-month prospective follow-upJ Pain2014151 24.e1 24.e2024373573
  • Golan-VeredYPudDChemotherapy-induced neuropathic pain and its relation to cluster symptoms in breast cancer patients treated with paclitaxelPain Pract2013131 46 5222533683
  • KohamaIIshikawaKKocsisJDSynaptic reorganization in the substantia gelatinosa after peripheral nerve neuroma formation: aberrant innervation of lamina II neurons by Abeta afferentsJ Neurosci2000204 1538 154910662843
  • WoolfCJThompsonSWThe induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity statesPain1991443 293 2991828878
  • PickeringGPereiraBDufourESouleSDubrayCImpaired modulation of pain in patients with postherpetic neuralgiaPain Res Manag2014191 e19 e2324427769
  • BannisterKPatelRGoncalvesLTownsonLDickensonAHDiffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitationsPain20151569 1803 181126010460
  • DubinAEPatapoutianANociceptors: the sensors of the pain pathwayJ Clin Invest201012011 3760 377221041958
  • MarwahaLBansalYSinghRSarojPBhandariRKuhadATRP channels: potential drug target for neuropathic painInflammopharmacology2016246 305 31727757589
  • MäntyselkäPKumpusaloEAhonenRPain as a reason to visit the doctor: a study in Finnish primary health carePain2001892–3 175 18011166473
  • BouhassiraDAttalNAlchaarHComparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)Pain20051141–2 29 3615733628
  • FreynhagenRBaronRGockelUTölleTRpainDETECT: a new screening questionnaire to identify neuropathic components in patients with back painCurr Med Res Opin20062210 1911 192017022849
  • MickGBaronRCorrea-IllanesGIs an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool based on IASP criteriaCurr Med Res Opin2014307 1357 136624650347
  • PickeringGPereiraBClèreFCognitive function in older patients with postherpetic neuralgiaPain Pract2014141 E1 E723701810
  • de León-CasasolaOAMayoralVThe topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidenceJ Pain Res20169 67 7926929664
  • AttalNCruccuGBaronREFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol2010179 1113 e8820402746
  • GammaitoniARAlvarezNAGalerBSSafety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literatureJ Clin Pharmacol2003432 111 11712616661
  • SheetsMFHanckDAMolecular action of lidocaine on the voltage sensors of sodium channelsJ Gen Physiol20031212 163 17512566542
  • SheetsMFHanckDAOutward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channelsJ Physiol2007582pt 1 317 33417510181
  • MeierTWasnerGFaustMEfficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled studyPain20031061–2 151 15814581122
  • MeierTFaustMHüppeMSchmuckerPReduktion chronischer Schmerzen bei nichtpostherpetischen peripheren Neuropathien nach topischer Behandlung mit Lidocainpflaster. [Reduction of chronic pain for non-postherpetic peripheral neuropathies after topical treatment with a lidocaine patch]Schmerz2004183 172 17815221421
  • RehmSBinderABaronRPost-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness studyCurr Med Res Opin2010267 1607 161920429825
  • LamVYWallaceMSchulteisGEffects of lidocaine patch on intradermal capsaicin-induced pain: a double-blind, controlled trialJ Pain2011123 323 33020889387
  • KrumovaEKZellerMWestermannAMaierCLidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibersPain20121532 273 28021995882
  • BaronRBinderAAttalNCasaleRDickensonAHTreedeR-DNeuropathic low back pain in clinical practiceEur J Pain2016206 861 87326935254
  • emc [webpage on the Internet]Versatis 5% Medicated Plaster – Summary of Product Characteristics2017 Available from: https://www.medicines.org.uk/emc/medicine/19291Accessed June 21, 2017
  • GalerBSRowbothamMCPeranderJFriedmanETopical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyPain1999803 533 53810342414
  • BaronRMayoralVLeijonGBinderASteigerwaldISerpellM5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT studyCurr Med Res Opin2009257 1663 167619485723
  • NavezMLMonellaCBöslISommerDDelormeC5% lidocaine medicated plaster for the treatment of postherpetic neuralgia: a review of the clinical safety and tolerabilityPain Ther201541 1 1525896574
  • WilhelmIRTzabazisALikarRSittlRGriessingerNLong-term treatment of neuropathic pain with a 5% lidocaine medicated plasterEur J Anaesthesiol2010272 169 17320010108
  • McCormackPLCapsaicin dermal patch: in non-diabetic peripheral neuropathic painDrugs20107014 1831 184220836576
  • HaanpääMTreedeR-DCapsaicin for neuropathic pain: linking traditional medicine and molecular biologyEur Neurol2012685 264 27523037991
  • SawynokJTopical and peripherally acting analgesicsPharmacol Rev2003551 1 2012615951
  • AnandPBleyKTopical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patchBr J Anaesth20111074 490 50221852280
  • DerrySLloydRMooreRAMcQuayHJTopical capsaicin for chronic neuropathic pain in adultsCochrane Database Syst Rev20094 CD00739319821411
  • BabbarSMarierJ-FMouksassiM-SPharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic painTher Drug Monit2009314 502 51019494795
  • Thomson, MicromedexDrug Information for the Health Care Professional1Greenwood Village, COThomson/MICROMEDEX2006
  • WalpoleCSWrigglesworthRBevanSAnalogues of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic “A-region”J Med Chem19933616 2362 23728360881
  • Reyes-Escogido MdeLGonzalez-MondragonEGVazquez-TzompantziEChemical and pharmacological aspects of capsaicinMolecules2011162 1253 127021278678
  • IrvingGABackonjaMRauckRWebsterLRTobiasJKVanhoveGFNGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgiaClin J Pain2012282 101 10721753727
  • LadjevicNGLikic-LadjevicISTopical glycopirrolate for the management of hyperhidrosis in herpetic neuralgiaYonsei Med J2009502 293 29519430567
  • HaanpääMLGourlayGKKentJLTreatment considerations for patients with neuropathic pain and other medical comorbiditiesMayo Clin Proc2010853 Suppl S15 S25
  • DerrySRiceASColePTanTMooreRATopical capsaicin (high concentration) for chronic neuropathic pain in adultsCochrane Database Syst Rev20171 CD00739328085183
  • DerrySMooreRATopical capsaicin (low concentration) for chronic neuropathic pain in adultsCochrane Database Syst Rev20129 CD01011122972149
  • LodgeDThe history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclatureNeuropharmacology2009561 6 2118765242
  • IlkjaerSDirksJBrennumJWernbergMDahlJBEffect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humansBr J Anaesth1997795 600 6059422898
  • AzevedoVMLaurettiGRPereiraNLReisMPTransdermal ketamine as an adjuvant for postoperative analgesia after abdominal gynecological surgery using lidocaine epidural blockadeAnesth Analg2000916 1479 148211094004
  • SawynokJTopical analgesics for neuropathic pain: preclinical exploration, clinical validation, future developmentEur J Pain2014184 465 48124108446
  • AnitescuMBenzonHTArgoffCEAdvances in topical analgesicsCurr Opin Anaesthesiol2013265 555 56123995062
  • KopskyDJKeppel HesselinkJMBhaskarAHaritonGRomanenkoVCasaleRAnalgesic effects of topical ketamineMinerva Anestesiol2015814 440 44924847738
  • FDA [webpage on the Internet]Import Alert 66-412016 [cited Nov 14, 2016]. Available from: http://www.accessdata.fda.gov/cms_ia/importalert_190.htmlAccessed July 5, 2017
  • BajajSWhitemanABrandnerBTransdermal drug delivery in pain managementContin Educ Anaesth Crit Care Pain2011112 39 43
  • WallaceMKudrowDMcElveenWClinical trial results: a randomized, double-blind, placebo-controlled trial of a three-day bupivacaine patch (ELADUR™) in patients with post-herpetic neuralgiaPoster session presented at: The American Pain Society 27th Annual Meeting2008Tampa, FL
  • AlessandriFLijoiDMistrangeloENicolettiACrosaMRagniNTopical diclofenac patch for postoperative wound pain in laparoscopic gynecologic surgery: a randomized studyJ Minim Invasive Gynecol2006133 195 20016698524
  • StanosSPGalluzziKETopical therapies in the management of chronic painPostgrad Med20131254 Suppl 1 25 3324547601
  • JorgeLLFeresCCTelesVETopical preparations for pain relief: efficacy and patient adherenceJ Pain Res20104 11 2421386951
  • MazièresBTopical ketoprofen patchDrugs R D200566 337 34416274258
  • AhmedSUZhangYChenLEffect of 1.5% topical diclofenac on clinical neuropathic painAnesthesiology20151231 191 19825955980
  • RascolOZesiewiczTChaudhuriKRA randomized controlled exploratory pilot study to evaluate the effect of rotigotine transdermal patch on Parkinson’s disease-associated chronic painJ Clin Pharmacol2016567 852 86126626320
  • GernerPKaoGSrinivasaVNarangSWangGKTopical amitriptyline in healthy volunteersReg Anesth Pain Med2003284 289 29312945021
  • LeclaireJde LacharriereOBretonLSociete L’Oreal SACosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonistsUS patent59584321999
  • JuifPEMelchiorMPoisbeauPCharacterization of the fast GABAergic inhibitory action of etifoxine during spinal nociceptive processing in male ratsNeuropharmacology201591 117 12225545681
  • AllegriMBaronRHansGA pharmacological treatment algorithm for localized neuropathic painCurr Med Res Opin2016322 377 38426641136
  • DerrySSven-RiceAColePTanTMooreRATopical capsaicin (high concentration) for chronic neuropathic pain in adultsCochrane Database Syst Rev20132 CD00739323450576
  • BarkinRLThe pharmacology of topical analgesicsPostgrad Med20131254 Suppl 1 7 18
  • PickeringGAntiepileptics for post-herpetic neuralgia in the elderly: current and future prospectsDrugs Aging2014319 653 66025178422
  • PickeringGLussierDANeuropathic painLussierDCrucianiRPain Management in the Elderly Patient: A Comprehensive Guide to Diagnosis and TreatmentNew YorkSpringer2017 In press 2017
  • HajjarERCafieroACHanlonJTPolypharmacy in elderly patientsAm J Geriatr Pharmacother200754 345 35118179993
  • PrianoLGascoMRMauroATransdermal treatment options for neurological disorders: impact on the elderlyDrugs Aging2006235 357 37516823990
  • CasaleRMattiaCBuilding a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plasterTher Clin Risk Manag201410 259 26824790451
  • SeminowiczDADavisKDA re-examination of pain-cognition interactions: implications for neuroimagingPain20071301–2 8 1317482364
  • OluigboCOSalmaARezaiARTargeting the affective and cognitive aspects of chronic neuropathic pain using basal forebrain neuromodulation: rationale, review and proposalJ Clin Neurosci2012199 1216 122122771143
  • WolfeGIBarohnRJPainful peripheral neuropathyCurr Treat Options Neurol200243 177 18811931724
  • PickeringGImpact of 5% lidocaine medicated plaster on allodynic symptoms of localized neuropathic pain after knee surgery2016 Available from: https://clinicaltrials.gov/ct2/show/NCT02763592?term=pickering+line&rank=1. NLM identifier: NCT02763592Accessed July 5, 2017
  • FrostSGTreatment of complex regional pain syndrome type 1 in a pediatric patient using the lidocaine patch 5%: a case reportCurr Ther Res Clin Exp2003648 626 62924944409
  • NayakSCunliffeMLidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five casesPaediatr Anaesth2008186 554 55818363625
  • RasolofoJPonceletMRousseauVMarec-BerardPEfficacité des emplâtres de lidocaïne 5 % sur les douleurs des crises vaso-occlusives chez l’enfant drépanocytaire. [Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease]Arch Pediatr2013207 762 76723731603
  • FriedrichsdorfSJNugentAPManagement of neuropathic pain in children with cancerCurr Opin Support Palliat Care201372 131 13823635878
  • FitzgeraldMThe development of nociceptive circuitsNat Rev Neurosci200567 507 52015995722
  • SarbackerGBTopical therapies for chronic pain management: a review of diclofenac and lidocaineUS Pharm2015403 35 38
  • GroningerHSchislerRETopical capsaicin for neuropathic pain #255J Palliat Med2012158 946 94722849599
  • ÜçeylerNSommerCHigh-dose capsaicin for the treatment of neuropathic pain: what we know and what we need to knowPain Ther201432 73 8425069571
  • SimpsonDMRobinson-PappJVanJCapsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled studyJ Pain2017181 42 5327746370
  • MogilJSSex differences in pain and pain inhibition: multiple explanations of a controversial phenomenonNat Rev Neurosci20121312 859 86623165262